Best Agrolife Peer Comparison

NSE: BESTAGRO | BSE: 539660

₹16.78

₹-0.10 (-0.59%)

As on 09-Oct-2026IST

Market cap

₹592 Cr

Revenue (TTM)

₹1,272 Cr

P/E Ratio

P/B Ratio

0.8

Div. Yield

0.6 %

Edit

	Best Agrolife	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Market cap (₹ Cr)	592	20,852	15,709	6,538	3,850
Revenue (₹ Cr)	1,272	3,245	5,595	5,357	2,962
Net Profit (₹ Cr)	29.60	579.39	732.10	626.21	214.00
Net Margin (%)	2.32	17.04	12.71	11.46	7.12
RoE (%)	3.75	17.35	24.05	21.55	13.45
Price to Earnings	20.01	35.99	21.46	10.44	17.99
Price-To-Book	0.82	5.79	4.78	2.03	1.78

Income Statement (₹ Cr)

	Best Agrolife	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Operating Revenue	1,271.63	3,244.88	5,595.40	5,356.54	2,962.00
Total Income	1,274.05	3,400.10	5,760.60	5,464.12	3,005.00
Total Expenditure	1,139.64	2,559.91	4,702.50	4,309.62	2,566.00
EBITDA	131.99	684.97	892.90	1,046.92	396.00
Depreciation	40.90	67.63	116.90	346.70	118.00
EBIT	91.09	617.34	776.00	700.22	278.00
Interest	54.66	8.16	19.40	3.01	8.00
Other Income	2.42	155.22	165.20	107.59	43.00
Exceptional Items	0.00	10.82	0.00	0.00	-24.00
Profit before Tax	38.85	775.21	921.80	804.80	289.00
Provision for Tax	9.25	195.82	189.70	178.58	75.00
Profit after Tax	29.60	579.39	732.10	626.21	214.00

	Best Agrolife	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Shareholder's Funds	768.77	3,389.67	2,965.70	3,136.49	2,043.00
Minority Interest	0.00	0.06	0.00	-0.09	0.00
Non-Current Liabilities	58.99	110.60	166.20	257.07	78.00
Current Liabilities	858.65	969.81	2,567.50	2,386.20	1,224.00
Total Liabilities	1,685.11	4,473.76	9,033.00	5,890.22	4,248.66

	Best Agrolife	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Non-Current Assets	287.57	941.45	598.20	1,259.56	844.00
Current Assets	1,311.83	3,340.15	4,918.30	4,438.10	2,309.00
Total Assets	1,685.11	4,473.76	9,033.00	5,890.22	4,248.66
Total Debt*	432.85	1.50	0.00	0.00	6.90
Net Current Assets	453.18	2,370.34	2,350.80	2,051.90	1,085.00
Contingent Liabilities	32.67	60.07	765.30	17.55	274.02

	Best Agrolife	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Cash From Operating Activities	97.44	445.51	1,078.50	655.69	172.11
Cash Flow from Investing Activities	0.71	-331.95	72.50	-513.07	-94.88
Cash from Financing Activities	-96.46	-82.88	-623.80	-118.28	-66.16
Net Cash Inflow / Outflow	1.69	30.68	527.20	24.34	11.07

	Best Agrolife	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
ROCE (%)	5.42	23.39	30.08	31.10	13.23
ROE (%)	3.75	17.35	24.05	21.55	13.45
ROA (%)	1.63	13.73	13.38	11.92	6.77
EBIT Margin (%)	7.16	19.02	13.87	13.07	9.39
Net Margin (%)	2.32	17.04	12.71	11.46	7.12
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Best Agrolife	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Revenue Growth (%)	-24.14	-3.61	-2.80	18.52	4.41
EBIT Growth (%)	-38.52	-0.95	22.55	68.35	25.23
Net Profit Growth (%)	-56.80	3.86	23.56	49.11	24.42
EPS Growth (%)	-44.09	2.55	23.56	49.11	60.86
Book Value Growth (%)	0.48	16.84	4.05	25.43	7.28

	Best Agrolife	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Price / Earnings	1.03	36.49	21.46	10.44	13.98
Price / Book Value	0.82	5.79	4.78	2.03	1.78
Dividend Yield (%)	0.60	0.31	4.29	2.07	1.52
EV/EBITDA	7.03	28.97	15.94	5.69	8.36
Market Cap (₹ Cr)	437.32	18,203.86	20,885.70	7,846.59	4,235.19

	Best Agrolife	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Debt to Equity	0.03	0.00	0.00	0.00	0.00
Short term debt to equity ratio	0.49	--	--	--	0.00
Current Ratio	1.53	3.44	1.92	1.86	1.89
Quick Ratio	0.77	2.65	1.08	1.39	1.10
Interest Coverage	1.71	95.97	48.52	268.73	37.13

	Best Agrolife	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Debtors to sales (%)	38.53	22.67	19.94	44.60	20.80
Asset Turnover	0.70	0.77	1.02	1.02	0.94
Receivable days	118.16	77.14	56.33	142.20	57.86
Inventory Days	159.66	74.64	122.54	68.45	85.52
Payable days	179.22	95.86	131.57	151.79	126.20
Cash Conversion Cycle	98.59	55.92	47.30	58.86	17.18

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.